Keyphrases
Gut Microbiome
100%
Diabetes
100%
Tuberculosis
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Pharmacokinetic Variability
100%
Drug Pharmacokinetics
75%
Active Tuberculosis
50%
Anti-tuberculosis Drugs
50%
Pharmacometrics
37%
Gut Microbiota Composition
25%
Alpha Diversity
25%
Tuberculosis Treatment
25%
Pharmacodynamics
25%
Human Gut Microbiota
25%
Infectious Diseases
25%
Specific Intent
25%
Gut Microbiota
25%
Without Diabetes
12%
Systems Biology
12%
Clinical Research
12%
Mentored Research
12%
Training Activities
12%
Formal Training
12%
Mentorship
12%
Tuberculosis-diabetes
12%
Patients with Diabetes
12%
Biomarker Predictors
12%
Clinical Systems
12%
PharmD
12%
Therapeutic Response
12%
Interdisciplinary Science
12%
Significant Knowledge
12%
Pharmacomicrobiomics
12%
Training Plan
12%
Large Set
12%
Mathematical Modeling
12%
Treatment Failure
12%
Clinical Translational
12%
Successful Completion
12%
Global Experts
12%
Knowledge Gaps
12%
Pharmacokinetics
12%
Patient-centered Research
12%
Microbiome Research
12%
Diabetes Inpatients
12%
Stool Specimen
12%
Quantitative Systems Pharmacology
12%
Treatment Response
12%
Integrated Plan
12%
Microbiome Variation
12%
Tuberculosis Patients
12%
Pharmacology
12%
Rifampin
12%
Human Microbiome Research
12%
Gut Dysbiosis
12%
Novel Mechanism
12%
Pyrazinamide
12%
Anti-tuberculosis
12%
Tuberculosis Treatment Outcomes
12%
Type 2 Diabetes Mellitus (T2DM)
12%
Scientific Justification
12%
Mellitus Diabetes
12%
Pharmacology, Toxicology and Pharmaceutical Science
Microbiome
100%
Pharmacokinetics
100%
Diabetes Mellitus
88%
Tuberculosis
44%
Tuberculostatic Agent
44%
Pharmacometrics
33%
Pharmacodynamics
22%
Intestine Flora
22%
Diseases
22%
Clinical Research
11%
Clinical Pharmacology
11%
Dysbiosis
11%
Pyrazinamide
11%
Isoniazid Plus Rifampicin
11%
Non Insulin Dependent Diabetes Mellitus
11%